HomeFBRX • NASDAQ
add
Forte Biosciences Inc
Previous close
$26.27
Year range
$4.90 - $35.62
Market cap
364.78M USD
Avg Volume
232.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.57M | 234.25% |
Net income | -24.79M | -246.44% |
Net profit margin | — | — |
Earnings per share | -1.45 | — |
EBITDA | -24.55M | -234.45% |
Effective tax rate | -4.37% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.96M | 31.85% |
Total assets | 82.78M | 34.47% |
Total liabilities | 21.79M | 139.93% |
Total equity | 60.99M | — |
Shares outstanding | 18.77M | — |
Price to book | 7.68 | — |
Return on assets | -68.30% | — |
Return on capital | -84.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -24.79M | -246.44% |
Cash from operations | -16.47M | -64.51% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 9.00K | -99.98% |
Net change in cash | -16.46M | -379.83% |
Free cash flow | -7.55M | -48.21% |
About
Founded
2007
Headquarters
Website
Employees
19
